RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Policies Germane to FTC Oversight of Healthcare Product Advertising and Promotion

Regulatory Policies Germane to FTC Oversight of Healthcare Product Advertising and Promotion

Posted 01 May 2008

The Food and Drug Administration (FDA) and Federal Trade Commission (FTC) have a symbiotic relationship in overseeing US healthcare product advertising and promotion. As a general rule, FTC regulates advertising for foods, over-the-counter drugs, dietary supplements, medical devices and cosmetics. FDA regulates the labeling for these products, as well as advertising and labeling for prescription drugs and restricted devices. This article focuses on advertising and promotional issues that are within FTC's jurisdiction.

 

© 2022 Regulatory Affairs Professionals Society.